Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Medcomm
|
June 10, 2026
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial
Zhicheng Lai, Aojie Ge, Hanyue Ouyang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 26, 2019
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy
Chenwei Wang, Wei He, Yichuan Yuan, et al.
Clinical and Translational Medicine
|
December 14, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1
Zhiyu Qiu, Chenwei Wang, Pinzhu Huang, et al.
Annals of Translational Medicine
|
September 21, 2020
Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
Wei He, Leen Liao, Dandan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study
Zefeng Du, Zhicheng Lai, Yexing Huang, et al.
International Journal of Clinical Oncology
|
June 5, 2024
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
Yuan Li, E-Er-Man-Bie-Ke Jin-Si-Han, Cheng Feng, et al.
International Journal of Surgery (London, England)
|
February 8, 2024
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study
Binkui Li, Chenwei Wang, Wei He, et al.
Oncogene
|
May 2, 2022
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling
Kai Li, Yi Niu, Yichuan Yuan, et al.
Cancer Research
|
January 31, 2014
Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma
Jian Hong, Yunfei Yuan, Jianping Wang, et al.
Digestive Surgery
|
November 5, 2020
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy
Yongjin Wang, Yadi Liao, Wenwu Liu, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Medcomm
|
June 10, 2026
Hepatic Arterial Infusion Chemotherapy plus either Toripalimab or Sorafenib as First-line Therapy for Locally Advanced Hepatocellular Carcinoma: A Non-comparative, Randomized Phase 2 Trial
Zhicheng Lai, Aojie Ge, Hanyue Ouyang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 26, 2019
Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy
Chenwei Wang, Wei He, Yichuan Yuan, et al.
Clinical and Translational Medicine
|
December 14, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1
Zhiyu Qiu, Chenwei Wang, Pinzhu Huang, et al.
Annals of Translational Medicine
|
September 21, 2020
Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study
Wei He, Leen Liao, Dandan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study
Zefeng Du, Zhicheng Lai, Yexing Huang, et al.
International Journal of Clinical Oncology
|
June 5, 2024
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
Yuan Li, E-Er-Man-Bie-Ke Jin-Si-Han, Cheng Feng, et al.
International Journal of Surgery (London, England)
|
February 8, 2024
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study
Binkui Li, Chenwei Wang, Wei He, et al.
Oncogene
|
May 2, 2022
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling
Kai Li, Yi Niu, Yichuan Yuan, et al.
Cancer Research
|
January 31, 2014
Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma
Jian Hong, Yunfei Yuan, Jianping Wang, et al.
Digestive Surgery
|
November 5, 2020
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy
Yongjin Wang, Yadi Liao, Wenwu Liu, et al.
Page
of 9